Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2025 Earnings Call Transcript March 12, 2026 Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics, Inc. fourth quarter ...
(NASDAQ:IBIO), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today announced the Company will host a conference call on Tuesday, March 17, at 4 ...
Deramiocel BLA for Duchenne muscular dystrophy under U.S. FDA review with PDUFA target action date of August 22, 2026Pivotal HOPE-3 Phase 3 trial ...
Intraoperative cardiac arrests (ICAs) are low-frequency, high-mortality and morbidity situations. Due to the rarity of occurrence, staff are often not adequately prepared to respond effectively.
ABSTRACT: A precise understanding of cardiac rhythm dynamics is fundamental for uncovering the mechanisms underlying arrhythmias and for guiding effective therapeutic strategies. In this study, we ...
Background Drug–drug interactions (DDIs) are a significant concern for patients on complex therapeutic regimens, especially involving cardiovascular medications, which are frequently implicated in ...
The widespread use of zinc oxide nanoparticles (ZnO NPs) has raised safety concerns on human health. However, the effects and underlying mechanisms of ZnO NPs exposure on the heart, especially during ...
hERG potassium channels are essential for repolarizing the ventricular action potential. Heteromeric hERG channels, which conduct cardiac I Kr, are formed by association of hERG1a and 1b subunits.
When a woman collapsed on an escalator at the Buffalo, New York, airport last June, Phil Clough knew what to do. He and another bystander put her flat on her back and checked her pulse (faint) and her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results